Shamburg News · 8-K filed Oct 15, 2026, 4:55 PM EDT
ALX Oncology Exchanges 13.35 Million Common Shares for Pre-Funded Warrants with Stockholders
ALXO · ALX ONCOLOGY HOLDINGS INC
- Material agreement
- Financing
- Materiality: medium
On October 14, 2026, ALX Oncology Holdings Inc. entered into privately negotiated exchange agreements with certain stockholders, under which the stockholders surrendered an aggregate of 13,353,384 shares of common stock in exchange for pre-funded warrants to purchase the same number of shares. The exchange is expected to settle on or about October 15, 2026. The pre-funded warrants have an exercise price of $0.001 per share and were issued in reliance on the Section 3(a)(9) exemption from registration.
Source: SEC EDGAR, Form 8-K, Items 1.01, 3.02, 9.01, accession 0001193125-26-422992.
Written from the filing by Shamburg Markets. Figures are as reported by the company.